STAT3 and neoplasm: Its mechanism is to inhibit NETs formation, reduce neutrophil recruitment and MPO expression in the liver and MDSCs in the lung and tumor by blocking P-selectin, inhibiting NF-κB and STAT3 signalling pathways.